Low-Dose statin shows promise for korean heart patients
NCT ID NCT03903029
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a low dose (10 mg) of the statin drug rosuvastatin in 242 Korean adults with high cholesterol or heart disease risk. The goal was to see how much it lowered 'bad' LDL cholesterol after 8 weeks. Results help guide cholesterol treatment in this population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A diet designed for puerto rico: can traditional foods fight heart disease and diabetes?
- Can a smartphone app help lower bad cholesterol?
- Heart drug showdown: which statin spares your blood sugar?
- Aerobic exercise may tame multiple chronic conditions in postmenopausal women
- Bee product may boost health in oral cancer survivors
- Could AI help pharmacists give better advice?